300 related articles for article (PubMed ID: 33024732)
1. Ceramide/Sphingomyelin Rheostat Regulated by Sphingomyelin Synthases and Chronic Diseases in Murine Models.
Taniguchi M; Okazaki T
J Lipid Atheroscler; 2020 Sep; 9(3):380-405. PubMed ID: 33024732
[TBL] [Abstract][Full Text] [Related]
2. Role of ceramide/sphingomyelin (SM) balance regulated through "SM cycle" in cancer.
Taniguchi M; Okazaki T
Cell Signal; 2021 Nov; 87():110119. PubMed ID: 34418535
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of sphingomyelin synthase (SMS) affects intracellular sphingomyelin accumulation and plasma membrane lipid organization.
Li Z; Hailemariam TK; Zhou H; Li Y; Duckworth DC; Peake DA; Zhang Y; Kuo MS; Cao G; Jiang XC
Biochim Biophys Acta; 2007 Sep; 1771(9):1186-94. PubMed ID: 17616479
[TBL] [Abstract][Full Text] [Related]
4. Chlamydia trachomatis-infected human cells convert ceramide to sphingomyelin without sphingomyelin synthases 1 and 2.
Tachida Y; Kumagai K; Sakai S; Ando S; Yamaji T; Hanada K
FEBS Lett; 2020 Feb; 594(3):519-529. PubMed ID: 31596951
[TBL] [Abstract][Full Text] [Related]
5. Regulation of sphingomyelin metabolism.
Bienias K; Fiedorowicz A; Sadowska A; Prokopiuk S; Car H
Pharmacol Rep; 2016 Jun; 68(3):570-81. PubMed ID: 26940196
[TBL] [Abstract][Full Text] [Related]
6. The role of sphingomyelin and sphingomyelin synthases in cell death, proliferation and migration-from cell and animal models to human disorders.
Taniguchi M; Okazaki T
Biochim Biophys Acta; 2014 May; 1841(5):692-703. PubMed ID: 24355909
[TBL] [Abstract][Full Text] [Related]
7. Regulation of death and growth signals at the plasma membrane by sphingomyelin synthesis: implications for hematological malignancies.
Lafont E; Kitatani K; Okazaki T; Ségui B
Recent Pat Anticancer Drug Discov; 2011 Sep; 6(3):324-33. PubMed ID: 21762071
[TBL] [Abstract][Full Text] [Related]
8. Biological functions of sphingomyelins.
Slotte JP
Prog Lipid Res; 2013 Oct; 52(4):424-37. PubMed ID: 23684760
[TBL] [Abstract][Full Text] [Related]
9. Sphingomyelinase induces lipid microdomain formation in a fluid phosphatidylcholine/sphingomyelin membrane.
Holopainen JM; Subramanian M; Kinnunen PK
Biochemistry; 1998 Dec; 37(50):17562-70. PubMed ID: 9860872
[TBL] [Abstract][Full Text] [Related]
10. Sphingomyelin and ceramide as regulators of development and lifespan.
Cutler RG; Mattson MP
Mech Ageing Dev; 2001 Jul; 122(9):895-908. PubMed ID: 11348657
[TBL] [Abstract][Full Text] [Related]
11. Epidermal permeability barrier function and sphingolipid content in the skin of sphingomyelin synthase 2 deficient mice.
Nomoto K; Itaya Y; Watanabe K; Yamashita T; Okazaki T; Tokudome Y
Exp Dermatol; 2018 Aug; 27(8):827-832. PubMed ID: 29345004
[TBL] [Abstract][Full Text] [Related]
12. Role of membrane sphingomyelin and ceramide in platform formation for Fas-mediated apoptosis.
Miyaji M; Jin ZX; Yamaoka S; Amakawa R; Fukuhara S; Sato SB; Kobayashi T; Domae N; Mimori T; Bloom ET; Okazaki T; Umehara H
J Exp Med; 2005 Jul; 202(2):249-59. PubMed ID: 16009715
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of sphingomyelin hydrolysis: targeting the lipid mediator ceramide as a key regulator of cellular fate.
Claus RA; Dorer MJ; Bunck AC; Deigner HP
Curr Med Chem; 2009; 16(16):1978-2000. PubMed ID: 19519377
[TBL] [Abstract][Full Text] [Related]
14. Ceramide signalling and the immune response.
Ballou LR; Laulederkind SJ; Rosloniec EF; Raghow R
Biochim Biophys Acta; 1996 Jun; 1301(3):273-87. PubMed ID: 8664339
[TBL] [Abstract][Full Text] [Related]
15. Disruption of sphingolipid metabolism augments ceramide-induced autophagy in preeclampsia.
Melland-Smith M; Ermini L; Chauvin S; Craig-Barnes H; Tagliaferro A; Todros T; Post M; Caniggia I
Autophagy; 2015 Apr; 11(4):653-69. PubMed ID: 25853898
[TBL] [Abstract][Full Text] [Related]
16. Cholesterol interactions with ceramide and sphingomyelin.
García-Arribas AB; Alonso A; Goñi FM
Chem Phys Lipids; 2016 Sep; 199():26-34. PubMed ID: 27132117
[TBL] [Abstract][Full Text] [Related]
17. Surface tension induced by sphingomyelin to ceramide conversion in lipid membranes.
López-Montero I; Vélez M; Devaux PF
Biochim Biophys Acta; 2007 Mar; 1768(3):553-61. PubMed ID: 17292325
[TBL] [Abstract][Full Text] [Related]
18. Switching head group selectivity in mammalian sphingolipid biosynthesis by active-site engineering of sphingomyelin synthases.
Kol M; Panatala R; Nordmann M; Swart L; van Suijlekom L; Cabukusta B; Hilderink A; Grabietz T; Mina JG; Somerharju P; Korneev S; Tafesse FG; Holthuis JC
J Lipid Res; 2016 Jul; 57(7):1273-85. PubMed ID: 27165857
[TBL] [Abstract][Full Text] [Related]
19. Sphingomyelin Synthases in Neuropsychiatric Health and Disease.
Mühle C; Bilbao Canalejas RD; Kornhuber J
Neurosignals; 2019; 27(S1):54-76. PubMed ID: 31877246
[TBL] [Abstract][Full Text] [Related]
20. The sphingomyelin synthase family: proteins, diseases, and inhibitors.
Chen Y; Cao Y
Biol Chem; 2017 Nov; 398(12):1319-1325. PubMed ID: 28742512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
